← All organizations
Highest phase reached
Phase 3
First clinical trial
Aug 1, 2009Last known activity
Feb 28, 2022
Timeline
2000s
- Jan 1, 2004
Immunovative Therapies— Founded
Drugs by trial phase (7 distinct, 15 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Indications
Studied for
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Squamous Cell
- Colorectal Neoplasms
- Head and Neck Neoplasms
- Leukemia
- Lymphoma
- Melanoma
- Multiple Myeloma
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Second Primary
- Ovarian Neoplasms
- Prostatic Neoplasms
- Recurrence
- Sarcoma
- Squamous Cell Carcinoma of Head and Neck
- Virus Diseases
Recent trials (22)
- NCT05033522Lead sponsorPhase 2/Phase 3Feb 28, 2022
- NCT04444622Lead sponsorPhase 2Jan 6, 2021
- NCT04441047Lead sponsorPhase 1/Phase 2Jan 6, 2021
- NCT01741038Lead sponsorPhase 2/Phase 3Dec 1, 2017
- NCT01741038Study directorPhase 2/Phase 3Dec 1, 2017
- NCT02624999Lead sponsorPhase 2Dec 1, 2016
- NCT02380443Lead sponsorPhase 2Sep 1, 2016
- NCT02409524Lead sponsorPhase 2Jul 1, 2016
- NCT02018419Lead sponsorPhase 1/Phase 2Mar 1, 2014
- NCT01998542Study directorPhase 1/Phase 2Dec 1, 2013
- NCT01995227Lead sponsorPhase 1/Phase 2Dec 1, 2013
- NCT01998542Lead sponsorPhase 1/Phase 2Dec 1, 2013
- NCT01923233Study directorPhase 1/Phase 2Nov 1, 2013
- NCT01923233Lead sponsorPhase 1/Phase 2Nov 1, 2013
- NCT00861965Study directorPhase 1/Phase 2Jan 1, 2010
Details
- Founded
- Jerusalem, IL Jan 1, 2004
- Last known activity
- Feb 28, 2022